THE VALUE OF PROGNOSTIC FACTORS FOR GLIOBLASTOMA TREATED WITH CONCURRENT THERMOCHEMORADIOTHERAPY
The treatment of patients with glioblastoma continues to be one of the greatest challenges. Glioblastoma is the most aggressive malignant primary brain tumor and is the most lethal among all cancers. Despite advances in the standard treatment, the prognosis for patients with glioblastoma remains poo...
Main Authors: | A. I. Ryabova, V. A. Novikov, O. V. Gribova, Zh. A. Startseva, E. G. Grigoriev, S. A. Glushchenko, A. A. Ponomaryova, V. A. Sirkashev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2018-11-01
|
Series: | Сибирский онкологический журнал |
Subjects: | |
Online Access: | https://www.siboncoj.ru/jour/article/view/855 |
Similar Items
-
ADJUVANT CHEMORADIOTHERAPY WITH LOCAL HYPERTHERMIA IN COMBINED TREATMENT OF PRIMARY GLIOBLASTOMA: PRELIMINARY RESULTS
by: A. I. Ryabova, et al.
Published: (2017-03-01) -
Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses
by: Niloy R. Datta, et al.
Published: (2020-06-01) -
Radiosensitization of Allogenic Subcutaneous C6 Glioma Model with Focused Ultrasound-Induced Mild Hyperthermia
by: Zhiyuan Xu, et al.
Published: (2024-03-01) -
Malignant hyperthermia: current approaches to prevention and treatment
by: E. S. Kim, et al.
Published: (2017-09-01) -
A translational review of hyperthermia biology
by: Mark W. Dewhirst
Published: (2025-12-01)